SAN FRANCISCO — A screening strategy combining fundus and OCT imaging improved the accuracy of age-related macular degeneration classification, according to data presented at the American Academy of Ophthalmology annual meeting.The bimodal deep convolu…
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in adults who are more than 50. A new study revealed that the condition might affect 77 million Europeans come 2050.
Eyevensys, a clinical-stage biotechnology company based in France, has developed a method to perform non-viral gene therapy in the eye, with the aim of treating ocular diseases. The system uses ocular electrotransfection to deliver therapeutic genes into the eye. Consisting of an ocular device and an electrical pulse generator, the system can deliv (Read more...)
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, reported financial and operating resul…
In October, the American Academy of Ophthalmology held its annual meeting in San Francisco.Healio/OSN was there to report on presentations and record videos with key opinion leaders.Here are the top five most popular articles and videos from our covera…
DUBLIN–(BUSINESS WIRE)–The “Vision Care Devices And Equipment Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering. The global vision care devices and equipment market was valued at about $27.6 billion in 2018 and is …